GlassScriptPhysician profile
Barbara Holdsworth
NPI 1477747186
$14,594.50
in general payments reported to CMS, 2019-2025
54 companies · $1,847 in 2025
The $1,847 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,299 · 2022: $2,789 · 2023: $3,695 · 2024: $3,965 · 2025: $1,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,407 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,406.73 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,023.08 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,301.01 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Mannkind Corporation | $1,082.19 | 2021-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $994.91 | 2021-2025 | Jardiance, Synjardy |
| Sanofi-Aventis U.S. LLC | $857.15 | 2021-2025 | |
| Abbott Laboratories | $780.76 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Astrazeneca Pharmaceuticals LP | $707.83 | 2021-2025 | Farxiga, Lokelma, Breztri |
| Amgen INC. | $672.52 | 2021-2025 | Evenity, Prolia, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $564.54 | 2022-2025 | |
| Medtronic, INC. | $520.08 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Minimed 770g |
| Corcept Therapeutics | $467.13 | 2022-2024 | Korlym |
| Tandem Diabetes Care, INC. | $388.09 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $374.10 | 2021-2025 | Tymlos |
| Dexcom, INC. | $368.52 | 2021-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $366.69 | 2021-2024 | Omnipod |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $344.12 | 2021-2025 | Recorlev, Gvoke Hypopen, Keveyis |
| Ascensia Diabetes Care US INC. | $287.04 | 2021-2025 | |
| Nevro Corp. | $258.63 | 2022-2024 | Senza |
| Abbvie INC. | $227.13 | 2021-2025 | |
| Recordati_rare_diseases_inc. | $223.48 | 2023-2024 | Isturisa, Signifor Lar |
| Astellas Pharma US INC | $182.33 | 2023-2025 | Veozah |
| Vistapharm, INC. | $149.22 | 2021 | |
| Amarin Pharma, INC. | $120.81 | 2021-2023 | |
| Amphastar Pharmaceuticals, INC. | $114.31 | 2024-2025 | |
| Acerus Pharmaceuticals Corporation | $90.35 | 2021-2022 | |
| Almatica Pharma LLC | $84.80 | 2024-2025 | Teriparatide, Loreev Xr |
| Ibsa Pharma INC. | $78.18 | 2021-2023 | Tirosint, Licart |
| Zealand Pharma US, INC. | $72.54 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $67.72 | 2024-2025 | |
| Kyowa Kirin, INC. | $65.79 | 2023 | Crysvita |
| Ascendis Pharma Endocrinology INC | $58.28 | 2025 | Yorvipath |
| Cequr Corporation | $56.86 | 2023 | Cequr Simplicity |
| Sequel Med Tech, LLC | $54.48 | 2025 | Twiist |
| Alexion Pharmaceuticals, INC. | $49.06 | 2021 | |
| Eisai INC. | $44.34 | 2021 | |
| Currax Pharmaceuticals LLC | $43.69 | 2021 | |
| Tolmar, INC. | $43.68 | 2023-2024 | |
| Azurity Pharmaceuticals, INC. | $39.02 | 2025 | Azmiro |
| Globus Medical, INC. | $33.63 | 2025 | Senza |
| Amryt Pharma Holdings LTD | $33.16 | 2021-2023 | Mycapssa |
| Esperion Therapeutics, INC. | $30.64 | 2021 | |
| Pfizer INC. | $30.50 | 2021-2023 | |
| Inari Medical, INC. | $29.03 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $28.96 | 2024 | |
| Madrigal Pharmaceuticals | $24.33 | 2024 | Resmetirom |
| Ultragenyx Pharmaceutical INC. | $20.15 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.85 | 2023 | Onpattro |
| Chiesi USA, INC. | $19.19 | 2024 | Myalept |
| Merck Sharp & Dohme LLC | $18.90 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $18.34 | 2021 | |
| Alvogen INC | $17.17 | 2023 | Teriparatide |
| Beta Bionics, INC. | $16.41 | 2023 | Ilet Bionic Pancreas |
| Kowa Pharmaceuticals America, INC. | $15.72 | 2022 | |
| Phadia US INC. | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Holdsworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.